Iraklis Chrysantzas
Research Subjects
Research Interests
Iraklis Chrysantzas has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Filippo Pedrazzoli
Department of Internal Medicine IRCCS Policlinico San Matteo, viale Golgi 19, Pavia 27100 Italy and University of Pavia, Strada Nuova, Pavia 27100; Italy.
1 shared publicationGiammaria Sitar
Department of Internal Medicine IRCCS Policlinico San Matteo, Pavia, Italy
1 shared publication- Luca Dezzani
Department of Internal Medicine IRCCS Policlinico San Matteo, Pavia, Italy
1 shared publication - Massimo Vincitorio
Department of Internal Medicine IRCCS Policlinico San Matteo, Pavia, Italy
1 shared publication - Vittorio Rosti
Center for the Study of Myelofibrosis, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy
1 shared publication
Latest Publications
- Open Access
- 20 September 2011
- Published by Springer Nature in Cancer Cell International
- Vol. 11 (1) , 1-10
Cell fusion in tumor progression: the isolation of cell fusion products by physical methods
Background: Cell fusion induced by polyethylene glycol (PEG) is an efficient but poorly controlled procedure for obtaining somatic cell hybrids used in gene mapping, monoclonal antibody production, and tumour immunotherapy. Genetic selection techniques and fluorescent cell sorting are usually employed to isolate cell fusion products, but both procedures have several drawbacks.Results: Here we describe a simple improvement in PEG-mediated cell fusion that was obtained by modifying the standard single-step procedure. We found that the use of two PEG undertreatments obtains a better yield of cell fusion products than the standard method, and most of these products are bi- or trinucleated polykaryocytes. Fusion rate was quantified using fluorescent cell staining microscopy. We used this improved cell fusion and cell isolation method to compare giant cells obtained in vitro and giant cells obtained in vivo from patients with Hodgkin's disease and erythroleukemia.Conclusions: In the present study we show how to improve PEG-mediated cell fusion and that cell separation by velocity sedimentation offers a simple alternative for the efficient purification of cell fusion products and to investigate giant cell formation in tumor development.
- 20 September 2011
- Published by Springer Nature in Cancer Cell International
- Vol. 11 (1) , 1-10
Open AccessCell fusion in tumor progression: the isolation of cell fusion products by physical methods
Background: Cell fusion induced by polyethylene glycol (PEG) is an efficient but poorly controlled procedure for obtaining somatic cell hybrids used in gene mapping, monoclonal antibody production, and tumour immunotherapy. Genetic selection techniques and fluorescent cell sorting are usually employed to isolate cell fusion products, but both procedures have several drawbacks.Results: Here we describe a simple improvement in PEG-mediated cell fusion that was obtained by modifying the standard single-step procedure. We found that the use of two PEG undertreatments obtains a better yield of cell fusion products than the standard method, and most of these products are bi- or trinucleated polykaryocytes. Fusion rate was quantified using fluorescent cell staining microscopy. We used this improved cell fusion and cell isolation method to compare giant cells obtained in vitro and giant cells obtained in vivo from patients with Hodgkin's disease and erythroleukemia.Conclusions: In the present study we show how to improve PEG-mediated cell fusion and that cell separation by velocity sedimentation offers a simple alternative for the efficient purification of cell fusion products and to investigate giant cell formation in tumor development.